The FDA has approved a new drug for the prevention of malaria. ARAKODA™, the brand name for Tafenoquine, will be produced in tablet form and used by those over the age of 18. Its approval presents a milestone after years of research and discovery in the antimalarial field.
Every year, the world comes together to celebrate the life and discoveries of the British doctor Sir Ronald Ross. You may not have heard of him but he is responsible for a revolution in malaria research.
“If you had asked me in January 2014 to explain what malaria was and how it was transmitted from person to person, I would not have known the answer” Joanne Power shares her PhD experience, including stories from Glasgow’s chip shops.
A groundbreaking by Durham University shows that a new type of mosquito net has the potential to prevent millions of cases of malaria.
Tafenoquine for the Prevention of Malaria: Lessons from Pentaquine, Quinacrine, Chloroquine, and Mefloquine
This month’s approval by the FDA of Tafenoquine would appear at first glance to mark the end of the U.S. military’s decades-long search for an effective causal prophylactic drug. Dr Remington Nevin of The Quinism Foundation explores why this isn’t the case.